25402013|t|Analgesic effects of morphine in combination with adjuvant drugs in rats.
25402013|a|BACKGROUND: Morphine is co-administered with adjuvant drugs to treat pain, nausea, vomiting, dyspnoea and delirium in cancer patients. AIM OF THE STUDY: To investigate analgesic effects of morphine when co-administered with adjuvant drugs. MATERIAL AND METHODS: Two-month-old male Wistar rats received single morphine doses alone (0.45 and 0.9 mg/kg) or with midazolam (0.3 mg/kg), haloperidol (0.15 and 0.45 mg/kg), levomepromazine (0.35 mg/kg), metoclopramide (1.0 mg/kg), and hyoscine butylbromide (1.7 mg/kg) as single subcutaneous injections. Analgesia was measured by the tail-flick test after 15, 30, 45, 60, and 90 min of drug administration. In the case of significant analgesia enhancement, analgesic and sedative effects were explored in 3-, 5-, 6-, 8-, and 11-month-old rats. RESULTS: Significant morphine (0.9 mg/kg) analgesia enhancement was observed 60 min after haloperidol (0.15 and 0.45 mg/kg) and hyoscine butylbromide co-administration. The addition of haloperidol to morphine significantly increased analgesia in 6-, 8- and 11-month-old rats while in the case of hyoscine butylbromide co-administration this effect was observed only in 11-month-old rats. CONCLUSIONS: Haloperidol and hyoscine butylbromide enhanced morphine analgesia. Future studies may explore the repeated administration of these drug combinations in rats and humans.
25402013	21	29	morphine	Chemical	MESH:D009020
25402013	68	72	rats	Species	10116
25402013	86	94	Morphine	Chemical	MESH:D009020
25402013	143	147	pain	Disease	MESH:D010146
25402013	149	155	nausea	Disease	MESH:D009325
25402013	157	165	vomiting	Disease	MESH:D014839
25402013	167	175	dyspnoea	Disease	
25402013	180	188	delirium	Disease	MESH:D003693
25402013	192	198	cancer	Disease	MESH:D009369
25402013	199	207	patients	Species	9606
25402013	263	271	morphine	Chemical	MESH:D009020
25402013	362	366	rats	Species	10116
25402013	383	391	morphine	Chemical	MESH:D009020
25402013	433	442	midazolam	Chemical	MESH:D008874
25402013	456	467	haloperidol	Chemical	MESH:D006220
25402013	491	506	levomepromazine	Chemical	MESH:D008728
25402013	521	535	metoclopramide	Chemical	MESH:D008787
25402013	553	574	hyoscine butylbromide	Chemical	MESH:D002086
25402013	622	631	Analgesia	Disease	MESH:D000699
25402013	752	761	analgesia	Disease	MESH:D000699
25402013	856	860	rats	Species	10116
25402013	883	891	morphine	Chemical	MESH:D009020
25402013	904	913	analgesia	Disease	MESH:D000699
25402013	952	963	haloperidol	Chemical	MESH:D006220
25402013	990	1011	hyoscine butylbromide	Chemical	MESH:D002086
25402013	1047	1058	haloperidol	Chemical	MESH:D006220
25402013	1062	1070	morphine	Chemical	MESH:D009020
25402013	1095	1104	analgesia	Disease	MESH:D000699
25402013	1132	1136	rats	Species	10116
25402013	1158	1179	hyoscine butylbromide	Chemical	MESH:D002086
25402013	1244	1248	rats	Species	10116
25402013	1263	1274	Haloperidol	Chemical	MESH:D006220
25402013	1279	1300	hyoscine butylbromide	Chemical	MESH:D002086
25402013	1310	1318	morphine	Chemical	MESH:D009020
25402013	1319	1328	analgesia	Disease	MESH:D000699
25402013	1415	1419	rats	Species	10116
25402013	1424	1430	humans	Species	9606
25402013	Positive_Correlation	MESH:D009020	MESH:D000699
25402013	Negative_Correlation	MESH:D009020	MESH:D009369
25402013	Negative_Correlation	MESH:D002086	MESH:D009020
25402013	Positive_Correlation	MESH:D009020	MESH:D014839
25402013	Positive_Correlation	MESH:D009020	MESH:D009325
25402013	Positive_Correlation	MESH:D009020	MESH:D003693
25402013	Negative_Correlation	MESH:D009020	MESH:D010146
25402013	Positive_Correlation	MESH:D006220	MESH:D000699
25402013	Negative_Correlation	MESH:D006220	MESH:D009020
25402013	Positive_Correlation	MESH:D002086	MESH:D000699

